ESMEXIL wurde mit sorgfältig ausgewählten, natürlichen Inhaltsstoffen formuliert und vereint eine einzigartige Kombination – für alle, die pflanzliche Qualität zu schätzen wissen.
Die Formulierung von ESMEXIL verbindet die Kraft der Natur mit wissenschaftlicher Präzision:
• Coffea Arabica: 315 mg
• Ginkgo Biloba: 18 mg
• Panax Ginseng: 18 mg
ESMEXIL – A scientifically based approach
With ESMEXIL, AYE EXOCURE pursues a rigorously scientific approach to supporting cognitive functions through plant-based active ingredients in a technologically optimized form. The foundation is a specially developed NanoExtract technology, in which purified plant extracts are reduced to a particle size of less than 200 nanometers. The goal is to significantly increase the bioavailability of the ingredients—thus creating the basis for effective, well-tolerated application.
Technology meets nature: An innovative concept for cognitive health
ESMEXIL is the world's first dietary supplement based on this specific NanoExtract platform. All active ingredients are 100% plant-based and vegan. The formulation was developed under strictly controlled conditions and is based on the latest scientific findings in neurobiology and pharmacokinetics.
Why nano formulations?
Plant microparticles with a size of less than 200 nanometers offer significant advantages, according to current research:
they can be distributed more specifically in the body,
enable faster recording,
and are considered potentially suitable for crossing the blood-brain barrier – a crucial aspect in the development of supportive substances for the central nervous system.
Nanotechnology thus opens up new perspectives in the integrative support of cognitive processes – in a natural, non-invasive way.
ESMEXIL: A dietary supplement with a scientific basis
Although ESMEXIL is classified as a food supplement under regulatory requirements, the formulation was developed based on current scientific data and is subject to strict internal quality standards. The advantage of this approach is faster availability to users – without having to wait for years of clinical approval procedures.
The development is based on a clear goal: to provide people with emerging cognitive challenges with plant-based, technically optimized support that is consistent with modern findings from research and practice.
